Notice Information
Notice Title
Project Manager/BSL3 Laboratory - Full and complete service for the duration of the project life cycle Validation Centre
Notice Description
Medicines Discovery Catapult (MDC) is a national facility for collaborative R&D exploring and developing new approaches to the discovery and proof of well targeted medicines, diagnostics and biomarkers. Funded by Innovate UK, an agency of the UK government, MDC are an independent not-for-profit company bringing together a fragmented UK sector of industry, academia, charities, technologists, services, finance companies, SMEs and start-ups who together can turn good science into new, high value products. By sharing problems, rare expertise and assets we support the growth of this new community through a time of radical business and national change. Capitalising on the success of the Lighthouse Lab to create a new BSL3 facility for innovative diagnostics, biomarkers and complex medicines and develop the UK's onshore diagnostic capability and capacity and the associated supply chain. The project will create a national facility for testing and validation of new diagnostics, biomarkers and innovative therapeutics for disease. The Validation Centre of Excellence will enable innovators to set up new companies with confidence, driving regional growth in high-value jobs and a sector of urgent national and global need. The Centre will build on the Lighthouse brand, creating a hub for new diagnostic and therapeutic validation. Project Manager: Further information can be found at https://procontract.due-north.com/RFx/RFxSummary?rfxId=0b0b42be-5298-eb11-810c-005056b64545#
Lot Information
Lot 1
Medicines Discovery Catapult (MDC) is a national facility for collaborative R&D exploring and developing new approaches to the discovery and proof of well targeted medicines, diagnostics and biomarkers. Funded by Innovate UK, an agency of the UK government, MDC are an independent not-for-profit company bringing together a fragmented UK sector of industry, academia, charities, technologists, services, finance companies, SMEs and start-ups who together can turn good science into new, high value products. By sharing problems, rare expertise and assets we support the growth of this new community through a time of radical business and national change. Capitalising on the success of the Lighthouse Lab to create a new BSL3 facility for innovative diagnostics, biomarkers and complex medicines and develop the UK's onshore diagnostic capability and capacity and the associated supply chain. The project will create a national facility for testing and validation of new diagnostics, biomarkers and innovative therapeutics for disease. The Validation Centre of Excellence will enable innovators to set up new companies with confidence, driving regional growth in high-value jobs and a sector of urgent national and global need. The Centre will build on the Lighthouse brand, creating a hub for new diagnostic and therapeutic validation. Project Manager: Further information can be found at https://procontract.due-north.com/RFx/RFxSummary?rfxId=0b0b42be-5298-eb11-810c-005056b64545#
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-h6vhtk-02a3c1
- Publication Source
- Find A Tender Service
- Latest Notice
- https://www.find-tender.service.gov.uk/Notice/007248-2021
- Current Stage
- Tender
- All Stages
- Tender
Procurement Classification
- Notice Type
- Tender Notice
- Procurement Type
- Standard
- Procurement Category
- Works
- Procurement Method
- Open
- Procurement Method Details
- Open procedure
- Tender Suitability
- Not specified
- Awardee Scale
- Not specified
Common Procurement Vocabulary (CPV)
- CPV Divisions
45 - Construction work
71 - Architectural, construction, engineering and inspection services
-
- CPV Codes
45000000 - Construction work
71000000 - Architectural, construction, engineering and inspection services
Notice Value(s)
- Tender Value
- Not specified
- Lots Value
- £55,000 Under £100K
- Awards Value
- Not specified
- Contracts Value
- Not specified
Notice Dates
- Publication Date
- 8 Apr 20214 years ago
- Submission Deadline
- 30 Apr 2021Expired
- Future Notice Date
- Not specified
- Award Date
- Not specified
- Contract Period
- Not specified - Not specified
- Recurrence
- Not specified
Notice Status
- Tender Status
- Active
- Lots Status
- Active
- Awards Status
- Not Specified
- Contracts Status
- Not Specified
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- MEDICINES DISCOVERY CATAPULT
- Contact Name
- Mr Kieran McGowan
- Contact Email
- kieran.mcgowan@md.catapult.org.uk
- Contact Phone
- +44 1625708394
Buyer Location
- Locality
- CHESHIRE
- Postcode
- SK10 4TG
- Post Town
- Stockport
- Country
- England
-
- Major Region (ITL 1)
- TLD North West (England)
- Basic Region (ITL 2)
- TLD6 Cheshire
- Small Region (ITL 3)
- TLD62 Cheshire East
- Delivery Location
- TLD62 Cheshire East
-
- Local Authority
- Cheshire East
- Electoral Ward
- Chelford
- Westminster Constituency
- Tatton
Further Information
Open Contracting Data Standard (OCDS)
View full OCDS Record for this contracting process
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.
{
"tag": [
"compiled"
],
"id": "ocds-h6vhtk-02a3c1-2021-04-08T13:59:27+01:00",
"date": "2021-04-08T13:59:27+01:00",
"ocid": "ocds-h6vhtk-02a3c1",
"initiationType": "tender",
"tender": {
"id": "DN536830",
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"title": "Project Manager/BSL3 Laboratory - Full and complete service for the duration of the project life cycle Validation Centre",
"status": "active",
"classification": {
"scheme": "CPV",
"id": "45000000",
"description": "Construction work"
},
"mainProcurementCategory": "works",
"description": "Medicines Discovery Catapult (MDC) is a national facility for collaborative R&D exploring and developing new approaches to the discovery and proof of well targeted medicines, diagnostics and biomarkers. Funded by Innovate UK, an agency of the UK government, MDC are an independent not-for-profit company bringing together a fragmented UK sector of industry, academia, charities, technologists, services, finance companies, SMEs and start-ups who together can turn good science into new, high value products. By sharing problems, rare expertise and assets we support the growth of this new community through a time of radical business and national change. Capitalising on the success of the Lighthouse Lab to create a new BSL3 facility for innovative diagnostics, biomarkers and complex medicines and develop the UK's onshore diagnostic capability and capacity and the associated supply chain. The project will create a national facility for testing and validation of new diagnostics, biomarkers and innovative therapeutics for disease. The Validation Centre of Excellence will enable innovators to set up new companies with confidence, driving regional growth in high-value jobs and a sector of urgent national and global need. The Centre will build on the Lighthouse brand, creating a hub for new diagnostic and therapeutic validation. Project Manager: Further information can be found at https://procontract.due-north.com/RFx/RFxSummary?rfxId=0b0b42be-5298-eb11-810c-005056b64545#",
"lots": [
{
"id": "1",
"description": "Medicines Discovery Catapult (MDC) is a national facility for collaborative R&D exploring and developing new approaches to the discovery and proof of well targeted medicines, diagnostics and biomarkers. Funded by Innovate UK, an agency of the UK government, MDC are an independent not-for-profit company bringing together a fragmented UK sector of industry, academia, charities, technologists, services, finance companies, SMEs and start-ups who together can turn good science into new, high value products. By sharing problems, rare expertise and assets we support the growth of this new community through a time of radical business and national change. Capitalising on the success of the Lighthouse Lab to create a new BSL3 facility for innovative diagnostics, biomarkers and complex medicines and develop the UK's onshore diagnostic capability and capacity and the associated supply chain. The project will create a national facility for testing and validation of new diagnostics, biomarkers and innovative therapeutics for disease. The Validation Centre of Excellence will enable innovators to set up new companies with confidence, driving regional growth in high-value jobs and a sector of urgent national and global need. The Centre will build on the Lighthouse brand, creating a hub for new diagnostic and therapeutic validation. Project Manager: Further information can be found at https://procontract.due-north.com/RFx/RFxSummary?rfxId=0b0b42be-5298-eb11-810c-005056b64545#",
"awardCriteria": {
"criteria": [
{
"name": "Price is not the only award criterion and all criteria are stated only in the procurement documents.",
"type": "quality",
"description": "80"
},
{
"type": "price",
"description": "20"
}
]
},
"value": {
"amount": 55000,
"currency": "GBP"
},
"contractPeriod": {
"durationInDays": 360
},
"hasRenewal": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "active"
}
],
"items": [
{
"id": "1",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "71000000",
"description": "Architectural, construction, engineering and inspection services"
}
],
"deliveryAddresses": [
{
"region": "UKD62"
}
],
"relatedLot": "1"
}
],
"submissionMethod": [
"electronicSubmission"
],
"submissionMethodDetails": "https://procontract.due-north.com/RFx/RFxSummary?rfxId=0b0b42be-5298-eb11-810c-005056b64545#",
"procurementMethod": "open",
"procurementMethodDetails": "Open procedure",
"coveredBy": [
"GPA"
],
"tenderPeriod": {
"endDate": "2021-04-30T12:00:00+01:00"
},
"submissionTerms": {
"languages": [
"en"
],
"bidValidityPeriod": {
"durationInDays": 90
}
},
"awardPeriod": {
"startDate": "2021-04-30T12:05:00+01:00"
},
"bidOpening": {
"date": "2021-04-30T12:05:00+01:00"
},
"hasRecurrence": false
},
"parties": [
{
"id": "GB-FTS-1022",
"name": "Medicines Discovery Catapult",
"identifier": {
"legalName": "Medicines Discovery Catapult"
},
"address": {
"streetAddress": "Block 35, Mereside, Alderley Park",
"locality": "Cheshire",
"region": "UKD62",
"postalCode": "SK10 4TG",
"countryName": "United Kingdom"
},
"contactPoint": {
"name": "Mr Kieran McGowan",
"telephone": "+44 1625708394",
"email": "Kieran.McGowan@md.catapult.org.uk",
"url": "https://procontract.due-north.com/RFx/RFxSummary?rfxId=0b0b42be-5298-eb11-810c-005056b64545#"
},
"roles": [
"buyer"
],
"details": {
"url": "https://md.catapult.org.uk/",
"buyerProfile": "https://md.catapult.org.uk/",
"classifications": [
{
"scheme": "TED_CA_TYPE",
"description": "Research - Drug Discovery / Health"
},
{
"scheme": "COFOG",
"description": "Research - Drug Discovery / Health"
}
]
}
},
{
"id": "GB-FTS-10403",
"name": "Medicines Discovery Catapult",
"identifier": {
"legalName": "Medicines Discovery Catapult"
},
"address": {
"streetAddress": "Block 35, Mereside, Alderley Park",
"locality": "Macclesfield",
"postalCode": "SK10 4TG",
"countryName": "United Kingdom"
},
"contactPoint": {
"email": "kieran.mcgowan@md.catapult.org.uk"
},
"roles": [
"reviewBody"
]
}
],
"buyer": {
"id": "GB-FTS-1022",
"name": "Medicines Discovery Catapult"
},
"language": "en"
}